Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Tate

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Clinical Biochemist. Reviews|October 3, 2007
Standardisation--the theory and the practiceJill Tate, Mauro Panteghini
The Clinical Biochemist. Reviews|May 7, 2008
Interferences in immunoassayJill Tate, Greg Ward
British Journal of Haematology|July 12, 2017
Monitoring of light chain myeloma - time for a changePeter Mollee, Jill Tate
The Clinical Biochemist. Reviews|April 9, 2008
Standardisation--the theory and the practiceJill Tate, Mauro Panteghini
American Journal of Clinical Pathology|July 17, 2009
Borderline high serum free light chain kappa/lambda ratios are seen not only in dialysis patients but also in non-dialysis-dependent renal impairment and inflammatory statesGeorge Marshall, Jill Tate, Peter Mollee
The Clinical Biochemist. Reviews|October 21, 2009
Monoclonal gammopathies--clinical and laboratory issuesJill Tate, Peter Mollee, Roger Johnson
The Clinical Biochemist. Reviews|October 24, 2013
Point-of-Care TestingRosy Tirimacco, Jill Tate, Roger Johnson
The Clinical Biochemist. Reviews|October 15, 2008
Analytical quality. PrefaceRoger Johnson, Mary Conroy, Jill Tate
Clinical Chemistry and Laboratory Medicine|August 13, 2013
Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosisPeter Mollee, Jill Tate, Carel J Pretorius
The Clinical Biochemist. Reviews|June 24, 2008
The reporting of cardiac troponinPeter E Hickman, Gus Koerbin, Jill Tate
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Clinical Biochemist. Reviews|October 3, 2007
Standardisation--the theory and the practiceJill Tate, Mauro Panteghini
The Clinical Biochemist. Reviews|May 7, 2008
Interferences in immunoassayJill Tate, Greg Ward
British Journal of Haematology|July 12, 2017
Monitoring of light chain myeloma - time for a changePeter Mollee, Jill Tate
The Clinical Biochemist. Reviews|April 9, 2008
Standardisation--the theory and the practiceJill Tate, Mauro Panteghini
American Journal of Clinical Pathology|July 17, 2009
Borderline high serum free light chain kappa/lambda ratios are seen not only in dialysis patients but also in non-dialysis-dependent renal impairment and inflammatory statesGeorge Marshall, Jill Tate, Peter Mollee
The Clinical Biochemist. Reviews|October 21, 2009
Monoclonal gammopathies--clinical and laboratory issuesJill Tate, Peter Mollee, Roger Johnson
The Clinical Biochemist. Reviews|October 24, 2013
Point-of-Care TestingRosy Tirimacco, Jill Tate, Roger Johnson
The Clinical Biochemist. Reviews|October 15, 2008
Analytical quality. PrefaceRoger Johnson, Mary Conroy, Jill Tate
Clinical Chemistry and Laboratory Medicine|August 13, 2013
Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosisPeter Mollee, Jill Tate, Carel J Pretorius
The Clinical Biochemist. Reviews|June 24, 2008
The reporting of cardiac troponinPeter E Hickman, Gus Koerbin, Jill Tate
Pageof 3